114 related articles for article (PubMed ID: 7064949)
21. Urinary excretion of pregnanetriol and 5 -pregnenetriol in two forms of congenital adrenal hyperplasia.
Bongiovanni AM; Eberlein WR; Moshang T
J Clin Invest; 1971 Dec; 50(12):2751-4. PubMed ID: 5129323
[TBL] [Abstract][Full Text] [Related]
22. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
[TBL] [Abstract][Full Text] [Related]
23. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.
Granoff AB
J Adolesc Health Care; 1981 Sep; 2(1):23-7. PubMed ID: 7333940
[TBL] [Abstract][Full Text] [Related]
24. Plasma adrenocorticotrophic hormone in congenital adrenal hyperplasia. Importance in long-term management.
LaFranchi S
Am J Dis Child; 1980 Nov; 134(11):1068-72. PubMed ID: 6254355
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of therapy in congenital adrenal hyperplasia.
Dauber A; Kellogg M; Majzoub JA
Clin Chem; 2010 Aug; 56(8):1245-51. PubMed ID: 20558634
[TBL] [Abstract][Full Text] [Related]
26. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.
Strott CA; Yoshimi T; Bardin CW; Lipsett MB
J Clin Endocrinol Metab; 1968 Jul; 28(7):1085-8. PubMed ID: 5660261
[No Abstract] [Full Text] [Related]
27. Circadian rhythm of plasma corticosteroids in congenital adrenal hyperplasia.
Reschini E; Giustina G; D'Alberton A; Crosignani PG
Clin Endocrinol (Oxf); 1974 Apr; 3(2):209-13. PubMed ID: 4837879
[No Abstract] [Full Text] [Related]
28. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE; Sizonenko PC
Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
[TBL] [Abstract][Full Text] [Related]
29. Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone.
Huseman CA; Varma MM; Blizzard RM; Johanson A
J Pediatr; 1977 Apr; 90(4):538-42. PubMed ID: 839364
[TBL] [Abstract][Full Text] [Related]
30. Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Rezvani I; Garibaldi LR; Digeorge AM; Artman HG
Pediatr Res; 1983 Feb; 17(2):131-4. PubMed ID: 6219334
[TBL] [Abstract][Full Text] [Related]
31. [Urinary excretion of pregnanetriol in various internal diseases].
Nagano T
Nihon Naibunpi Gakkai Zasshi; 1966 Dec; 42(9):1035-47. PubMed ID: 4291583
[No Abstract] [Full Text] [Related]
32. Androglottia in a young female adolescent with congenital adrenal hyperplasia and 21-hydroxylase deficiency.
Fürst-Recktenwald S; Dörr HG; Rosanowski F
J Pediatr Endocrinol Metab; 2000; 13(7):959-62. PubMed ID: 10968487
[TBL] [Abstract][Full Text] [Related]
33. Hormonal and clinical responses to prednisone treatment in adolescents with congenital adrenal hyperplasia.
Zipf WB; Bacon GE; Kelch RP
Horm Res; 1980; 12(4):206-17. PubMed ID: 6446517
[TBL] [Abstract][Full Text] [Related]
34. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
Winterer J; Chrousos GP; Loriaux DL; Cutler GB
J Pediatr; 1985 Jan; 106(1):137-42. PubMed ID: 3871229
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of congenital adrenal hyperplasia with 11-hydroxylase deficiency by determination of tetrahydro-11-desoxycortisol in urine.
Knorr D; Bidlingmaier F
Helv Paediatr Acta; 1974; Suppl 34():119-25. PubMed ID: 4452634
[No Abstract] [Full Text] [Related]
36. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Einaudi S; Lala R; Corrias A; Matarazzo P; Pagliardini S; de Sanctis C
J Pediatr Endocrinol; 1993; 6(2):173-8. PubMed ID: 8348221
[TBL] [Abstract][Full Text] [Related]
37. Capillary gas chromatography as a tool for characterization of urinary steroid excretion in patients with congenital adrenal hyperplasia.
Vierhapper H; Nowotny P; Waldhäusl W; Frisch H
J Steroid Biochem; 1985 Mar; 22(3):363-9. PubMed ID: 3990286
[TBL] [Abstract][Full Text] [Related]
38. Blood testosterone values in patients with congenital virilizing adrenal hyperplasia.
Solomon IL; Schoen EJ; Donelan L; Brandt-Erichsen D
J Clin Endocrinol Metab; 1975 Mar; 40(3):355-62. PubMed ID: 163840
[TBL] [Abstract][Full Text] [Related]
39. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
Jansen M; Wit JM; van den Brande JL
Acta Paediatr Scand; 1981 Mar; 70(2):229-33. PubMed ID: 7015786
[TBL] [Abstract][Full Text] [Related]
40. Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-beta-hydroxysteroid dehydrogenase. Case report of a surviving girl and steroid studies.
Zachmann M; Vollmin JA; Murset G; Curtius HC; Prader A
J Clin Endocrinol Metab; 1970 Jun; 30(6):719-26. PubMed ID: 4315485
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
